ARA-290
ARA-290 (also studied under the name cibinetide) is supplied as an erythropoietin-derived peptide for innate repair receptor (EPOR/CD131) pathway research, distinct from the hematopoietic (blood-cell) receptor pathway native erythropoietin acts on. Supplied strictly for laboratory and educational research. Not for human or veterinary use.
Vial amount
Purchase option
Checkout includes a research-use attestation. Materials are supplied only for laboratory and educational research.
ARA-290 in research
ARA-290 (also studied under the name cibinetide) is supplied as an erythropoietin-derived peptide for innate repair receptor (EPOR/CD131) pathway research, distinct from the hematopoietic (blood-cell) receptor pathway native erythropoietin acts on.
Immune-signaling, barrier, and inflammation-model research for laboratory workflows.
Bench context
Supplied as a research-grade reference material for documented laboratory and educational research workflows.
Available amounts
Select from the stocked vial amounts for ARA-290 before adding the material to cart.
Claims discipline
No protocol instructions, no dosing, no medical advice, and no therapeutic or human-use promises.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, not a drug or supplement.
As listed by the supplier in BioRegen's ordering system, shown here exactly as written for transparency. This is the vendor's own description, not independently verified, edited, or endorsed by BioRegen, and is not a BioRegen claim of any effect.
5mg
Disclaimer: All products on this site are for Research and Development use only. Products are Not for Human Consumption of any kind. The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Ara-290 is garnering attention in the scientific community for its potential to support cellular health and aid in the modulation of inflammatory responses. This peptide is part of a new wave of research that seeks to unlock its capabilities in enhancing tissue repair and reducing inflammation-related damage. By focusing on these key areas, Ara-290 offers a promising avenue for researchers aiming to explore innovative solutions to complex biological challenges.
Ongoing studies are delving into its unique interactions at the cellular level, offering insights into how it might be used to mediate inflammatory processes. Early anecdotal evidence suggests that Ara-290 could play a role in the body's natural repair mechanisms, although more research is needed to fully understand its effects.
Join the forefront of peptide research by incorporating Ara-290 into your studies, and be part of the exploration of its potential benefits in scientific discovery. Whether your focus is on basic science or applied research, Ara-290 could be a valuable component of your laboratory toolkit.
10mg
Disclaimer: All products on this site are for Research and Development use only. Products are Not for Human Consumption of any kind. The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Ara-290, an innovative peptide, is garnering attention in the scientific community for its potential therapeutic benefits, particularly in the fields of inflammation and tissue repair. Originating from the structure of erythropoietin (EPO), Ara-290 is designed to interact with specific receptors in the body without inducing the red blood cell production typically associated with EPO. This makes it a fascinating subject for researchers exploring new treatments for chronic pain and inflammatory diseases.
The peptide's unique properties and selective receptor affinity may contribute to its ability to support neuroprotection and regeneration, opening exciting possibilities in regenerative medicine. While still under extensive research, anecdotal evidence suggests potential applications in managing conditions like neuropathy and autoimmune disorders.
Researchers are particularly interested in how Ara-290 might offer protective effects in nerve cells, potentially paving the way for breakthroughs in treating nerve damage and enhancing recovery processes. By mitigating inflammation and promoting healing, Ara-290 holds promise as a valuable tool in laboratory settings focused on therapeutic advancement.